SEC Filings | NeuroBo Pharmaceuticals, Inc.

Filing date	Form	Description	Filing Group	View
Mar 30, 2023	10-K	Annual report which provides a comprehensive overview of the company for the past year	Annual Filings	0001558370-23-005127.rtf 0001558370-23-005127.xls 0001558370-23-005127.pdf View HTML
Mar 28, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	Other	0001971160-23-000005.rtf 0001971160-23-000005.pdf View HTML
Mar 27, 2023	8-K/A	Amendment to a previously filed 8-K	Current Reports	0001104659-23-037169.rtf 0001104659-23-037169.xls 0001104659-23-037169.pdf View HTML
Mar 13, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001104659-23-031406.rtf 0001104659-23-031406.xls 0001104659-23-031406.pdf View HTML
Feb 14, 2023	SC 13G/A	An amendment to the SC 13G filing	Other	0001387131-23-001998.rtf 0001387131-23-001998.xls 0001387131-23-001998.pdf View HTML
Feb 9, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001104659-23-017612.rtf 0001104659-23-017612.xls 0001104659-23-017612.pdf View HTML
Feb 1, 2023	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Registration Statements	0001104659-23-009350.rtf 0001104659-23-009350.xls 0001104659-23-009350.pdf View HTML
Jan 31, 2023	EFFECT	EFFECT	Other	9999999995-23-000244.rtf 9999999995-23-000244.xls 9999999995-23-000244.pdf View HTML
Jan 27, 2023	CORRESP	CORRESP	Other	0001104659-23-007453.rtf 0001104659-23-007453.xls 0001104659-23-007453.pdf View HTML
Jan 25, 2023	UPLOAD	UPLOAD	Other	0000000000-23-000829.rtf 0000000000-23-000829.pdf View HTML

Data provided by Kaleidoscope.